Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | CCR1 | P32246 | 2/20 | 0.46 |
| ▸ | CCR5 | P51681 | 2/20 | 0.46 |
| ▸ | CCR8 | P51685 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | METAP1 | P53582 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29942138 | 1.00 | TGFBR1 (0.47) | TGFBR1KDM4ELMNACCR1CCR5 | |
| SCHEMBL787679 | 0.95 | TGFBR1 (0.46) | TGFBR1KDM4ELMNACCR1CCR5 | |
| Hydrochloric Acid SCHEMBL1572132 | 0.93 | TGFBR1 (0.45) | TGFBR1KDM4ELMNACCR1CCR5 | |
| SCHEMBL32689469 | 0.93 | TGFBR1 (0.45) | TGFBR1KDM4ELMNACCR1CCR5 | |
| Hydrochloric Acid SCHEMBL2455950 | 0.93 | TGFBR1 (0.45) | TGFBR1KDM4ELMNACCR1CCR5 | |
| Dipyridyl SCHEMBL7511159 | 0.93 | KDM4E (0.48) | TGFBR1KDM4ELMNACCR1CCR5 | |
| Dipyridyl SCHEMBL4595525 | 0.93 | KDM4E (0.48) | TGFBR1KDM4ELMNACCR1CCR5 | |
| SCHEMBL2455952 | 0.89 | TGFBR1 (0.42) | TGFBR1KDM4ELMNACCR1CCR5 | |
| SCHEMBL230110 | 0.88 | KDM4E (0.54) | TGFBR1KDM4ELMNACCR1CCR5 | |
| SCHEMBL17045822 | 0.86 | KDM4E (0.52) | TGFBR1KDM4ELMNACCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952321-B2 | Method for the hydrodeoxygenation of oxygenated compounds to unsaturated products | TOTALENERGIES ONETECH BELGIUM S.A. (BE) | 2024-04-09 | — | — | US | disclosed |
| CN-114933711-B | Preparation of organic supermolecular ball and application of organic supermolecular ball in iodine adsorption | 黔南民族师范学院 | 2023-09-15 | — | — | CN | disclosed |
| US-20220356126-A1 | METHOD FOR THE HYDRODEOXYGENATION OF OXYGENATED COMPOUNDS TO UNSATURATED PRODUCTS | TOTALENERGIES ONETECH BELGIUM S.A. (BE) | 2022-11-10 | — | — | US | disclosed |
| CN-114933711-A | Preparation of organic supermolecule ball and application thereof in iodine adsorption | 黔南民族师范学院 | 2022-08-23 | — | — | CN | disclosed |
| CN-114773614-A | Bimetal controllable distribution supramolecular material and preparation method thereof | 吉林大学 | 2022-07-22 | — | — | CN | disclosed |
| EP-3990418-A1 | METHOD FOR THE HYDRODEOXYGENATION OF OXYGENATED COMPOUNDS TO UNSATURATED PRODUCTS | Katholieke Universiteit Leuven (BE) | 2022-05-04 | — | — | EP | disclosed |
| US-8309304-B2 | composition for detecting and/or characterizing a multiple-charged biomolecule comprising a charged d8 or d10 metal complex, wherein the metal complex electrostatically binds to the multiple-charged biomolecule to induce aggregation and self-assembly of the metal complex through metal-metal interactions, | THE UNIVERSITY OF HONG KONG (CN) | 2012-11-13 | — | — | US | disclosed |
| US-20110006272-A1 | Electrochromic films prepared by supramolecular self-assembly | BASF SE (DE) | 2011-01-13 | — | — | US | disclosed |
| JP-2010209047-A | PHENYL-TERPYRIDINE COMPOUND, COMPLEX COMPOUND OR COMPOUNDED MATERIAL, METHOD FOR PRODUCING THEM, LIGHT-EMITTING MATERIAL CONTAINING THEM AND DETECTING MATERIAL OF ORGANIC COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY | 2010-09-24 | — | — | JP | disclosed |
| WO-2010069797-A1 | ELECTROCHROMIC FILMS PREPARED BY SUPRAMOLECULAR SELF-ASSEMBLY | BASF SE (DE) | 2010-06-24 | — | — | WO | disclosed |
| US-20080153103-A1 | Label-Free Optical Sensing and Characterization of Biomolecules by D8 or D10 Metal Complexes | UNIVERSITY OF HONG KONG, THE (HK) | 2008-06-26 | — | — | US | disclosed |
| US-20050064468-A1 | concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports | IBC ADVANCED TECHNOLOGIES, INC. | 2005-03-24 | — | — | US | disclosed |
| US-6774082-B2 | COMPOSITION FOR USE IN THE SEPARATION OF PREFERENTIAL BIOPOLYMERS FROM SAMPLE | IBC ADVANCED TECHNOLOGIES, INC. | 2004-08-10 | — | — | US | disclosed |
| US-20030050458-A1 | Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences | IBC ADVANCED TECHNOLOGIES, INC. | 2003-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050458-A1 | Compositions and methods for separating heterocyclic aromatic amine bases, nucleosides, nucleotides, and nucleotide sequences | NUDT1, ATIC, PNP | TGFBR1 1531/4885KDM4E 2013/4885LMNA 1739/4885 |
| US-20050064468-A1 | concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports | NUDT1, PCNA, NSUN2 | TGFBR1 1666/4885KDM4E 2348/4885LMNA 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.